^
HER-2 positive
HER2 Positive Breast Cancer
trastuzumab + pertuzumab
Sensitive
:
A1
J Clin Oncol - 4d
HER-2 positive
HER2 Positive Breast Cancer
ado-trastuzumab emtansine
Sensitive
:
A1
BMC Cancer - 4d
HER-2 positive
HER2 Positive Breast Cancer
trastuzumab
Sensitive
:
A1
ESMO-BC 2021 - 5d
HER-2 positive
HER2 Positive Breast Cancer
neratinib
Sensitive
:
A1
ESMO-BC 2021 - 5d
HER-2 positive
HER2 Positive Breast Cancer
trastuzumab + tucatinib
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
margetuximab
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
fam-trastuzumab deruxtecan-nxki
Sensitive
:
A1
HR positive
HER2 Positive Breast Cancer
neratinib
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
pertuzumab/trastuzumab/hyaluronidase-zzxf
Sensitive
:
A1
HER-2 amplification
HER2 Positive Breast Cancer
Trazimera (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
Trazimera (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 amplification
HER2 Positive Breast Cancer
Ontruzant (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
Ontruzant (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 amplification
HER2 Positive Breast Cancer
Ogivri (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
Ogivri (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 amplification
HER2 Positive Breast Cancer
Kanjinti (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
Kanjinti (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 amplification
HER2 Positive Breast Cancer
Herzuma (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
Herzuma (trastuzumab biosimilar)
Sensitive
:
A1
HR positive
HER2 Positive Breast Cancer
Zercepac (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
trastuzumab
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
Zercepac (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 positive
HER2 Positive Breast Cancer
TCHP
Sensitive
:
A2
ER positive
HER2 Positive Breast Cancer
trastuzumab + lapatinib
Sensitive
:
A2
HER-2 positive
HER2 Positive Breast Cancer
TCH
Sensitive
:
A2
HER-2 positive
HER2 Positive Breast Cancer
trastuzumab + lapatinib
Sensitive
:
A2
HR positive
HER2 Positive Breast Cancer
trastuzumab
Sensitive
:
A2
HER-2 positive
HER2 Positive Breast Cancer
pertuzumab
Sensitive
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our